Bayer cross
Pharma

FDA christens Hyrnuo a first-line option for rare lung cancer

The FDA expanded Hyrnuo's indication to include first-line treatment, amping up the med's rivalry with Boehringer Ingelheim's Hernexeos.
Donavyn Coffey Sep 9, 2026 4:33pm
math equations chalkboard multiplication chalk multiply

Caris lassos Kevin Costner for new Caris Detect ad

Sep 9, 2026 1:18pm
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Merck to lay off another 54 at New Jersey HQ

Sep 9, 2026 11:10am
Biomarin

BioMarin dishes ph. 3 results as Voxzogo expansion push underway

Sep 9, 2026 10:28am
FDA

FDA solidifies leadership posts at CDER, CBER

Sep 9, 2026 9:00am
Complicated formula on chalkboard

Pricing policy ‘earthquake’ forcing commercial rethink: survey

Sep 9, 2026 12:00am
More News

Sandoz sets ambitious goal to grow biosimilar bona fides by 2040

Sep 8, 2026 2:45pm

Amgen’s Imdelltra scores overall survival win in first-line SCLC

Sep 8, 2026 11:42am

Wegovy helps free 40% of kids from obesity in phase 3 trial

Sep 8, 2026 11:07am

FDA's surprise approval of AZ's oral SERD sets new paradigm

Sep 8, 2026 10:35am